The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Mosapride is a gastroprokinetic agent that acts as a selective 5HT4 agonist. The major active metabolite of mosapride, known as M1, additionally acts as a 5HT3 antagonist,which accelerates gastric emptying throughout the whole of the gastrointestinal tract in humans,and is used for the treatment of gastritis, gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome.
The global Mosapride market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Mosapride is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Mosapride is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Mosapride in Gastritis is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Mosapride include Sumitomo Dainippon Pharma, Konghong Pharmaceutical, Dainippon Pharmaceutical Co., Ltd., Nihon Generic, NIPPON CHEMIPHAR CO., LTD., Lunan Pharmaceutical Group, HAOSON PHARMA, DAIICHI SANKYO and SAWAI PHARMACEUTICAL CO., LTD., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Mosapride, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mosapride.
Report Scope
The Mosapride market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Mosapride market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mosapride companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sumitomo Dainippon Pharma
Konghong Pharmaceutical
Dainippon Pharmaceutical Co., Ltd.
Nihon Generic
NIPPON CHEMIPHAR CO., LTD.
Lunan Pharmaceutical Group
HAOSON PHARMA
DAIICHI SANKYO
SAWAI PHARMACEUTICAL CO., LTD.
Segment by Type
Tablet
Capsule
Others
Segment by Application
Gastritis
Dyspepsia
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Mosapride companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Mosapride is a gastroprokinetic agent that acts as a selective 5HT4 agonist. The major active metabolite of mosapride, known as M1, additionally acts as a 5HT3 antagonist,which accelerates gastric emptying throughout the whole of the gastrointestinal tract in humans,and is used for the treatment of gastritis, gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome.
The global Mosapride market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Mosapride is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Mosapride is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Mosapride in Gastritis is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Mosapride include Sumitomo Dainippon Pharma, Konghong Pharmaceutical, Dainippon Pharmaceutical Co., Ltd., Nihon Generic, NIPPON CHEMIPHAR CO., LTD., Lunan Pharmaceutical Group, HAOSON PHARMA, DAIICHI SANKYO and SAWAI PHARMACEUTICAL CO., LTD., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Mosapride, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mosapride.
Report Scope
The Mosapride market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Mosapride market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mosapride companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sumitomo Dainippon Pharma
Konghong Pharmaceutical
Dainippon Pharmaceutical Co., Ltd.
Nihon Generic
NIPPON CHEMIPHAR CO., LTD.
Lunan Pharmaceutical Group
HAOSON PHARMA
DAIICHI SANKYO
SAWAI PHARMACEUTICAL CO., LTD.
Segment by Type
Tablet
Capsule
Others
Segment by Application
Gastritis
Dyspepsia
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Mosapride companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Mosapride Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Tablet
1.2.3 Capsule
1.2.4 Others
1.3 Market by Application
1.3.1 Global Mosapride Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Gastritis
1.3.3 Dyspepsia
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Mosapride Market Perspective (2019-2030)
2.2 Mosapride Growth Trends by Region
2.2.1 Global Mosapride Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Mosapride Historic Market Size by Region (2019-2024)
2.2.3 Mosapride Forecasted Market Size by Region (2025-2030)
2.3 Mosapride Market Dynamics
2.3.1 Mosapride Industry Trends
2.3.2 Mosapride Market Drivers
2.3.3 Mosapride Market Challenges
2.3.4 Mosapride Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Mosapride Players by Revenue
3.1.1 Global Top Mosapride Players by Revenue (2019-2024)
3.1.2 Global Mosapride Revenue Market Share by Players (2019-2024)
3.2 Global Mosapride Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Mosapride Revenue
3.4 Global Mosapride Market Concentration Ratio
3.4.1 Global Mosapride Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mosapride Revenue in 2023
3.5 Mosapride Key Players Head office and Area Served
3.6 Key Players Mosapride Product Solution and Service
3.7 Date of Enter into Mosapride Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Mosapride Breakdown Data by Type
4.1 Global Mosapride Historic Market Size by Type (2019-2024)
4.2 Global Mosapride Forecasted Market Size by Type (2025-2030)
5 Mosapride Breakdown Data by Application
5.1 Global Mosapride Historic Market Size by Application (2019-2024)
5.2 Global Mosapride Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Mosapride Market Size (2019-2030)
6.2 North America Mosapride Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Mosapride Market Size by Country (2019-2024)
6.4 North America Mosapride Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Mosapride Market Size (2019-2030)
7.2 Europe Mosapride Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Mosapride Market Size by Country (2019-2024)
7.4 Europe Mosapride Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Mosapride Market Size (2019-2030)
8.2 Asia-Pacific Mosapride Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Mosapride Market Size by Region (2019-2024)
8.4 Asia-Pacific Mosapride Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Mosapride Market Size (2019-2030)
9.2 Latin America Mosapride Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Mosapride Market Size by Country (2019-2024)
9.4 Latin America Mosapride Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Mosapride Market Size (2019-2030)
10.2 Middle East & Africa Mosapride Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Mosapride Market Size by Country (2019-2024)
10.4 Middle East & Africa Mosapride Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sumitomo Dainippon Pharma
11.1.1 Sumitomo Dainippon Pharma Company Detail
11.1.2 Sumitomo Dainippon Pharma Business Overview
11.1.3 Sumitomo Dainippon Pharma Mosapride Introduction
11.1.4 Sumitomo Dainippon Pharma Revenue in Mosapride Business (2019-2024)
11.1.5 Sumitomo Dainippon Pharma Recent Development
11.2 Konghong Pharmaceutical
11.2.1 Konghong Pharmaceutical Company Detail
11.2.2 Konghong Pharmaceutical Business Overview
11.2.3 Konghong Pharmaceutical Mosapride Introduction
11.2.4 Konghong Pharmaceutical Revenue in Mosapride Business (2019-2024)
11.2.5 Konghong Pharmaceutical Recent Development
11.3 Dainippon Pharmaceutical Co., Ltd.
11.3.1 Dainippon Pharmaceutical Co., Ltd. Company Detail
11.3.2 Dainippon Pharmaceutical Co., Ltd. Business Overview
11.3.3 Dainippon Pharmaceutical Co., Ltd. Mosapride Introduction
11.3.4 Dainippon Pharmaceutical Co., Ltd. Revenue in Mosapride Business (2019-2024)
11.3.5 Dainippon Pharmaceutical Co., Ltd. Recent Development
11.4 Nihon Generic
11.4.1 Nihon Generic Company Detail
11.4.2 Nihon Generic Business Overview
11.4.3 Nihon Generic Mosapride Introduction
11.4.4 Nihon Generic Revenue in Mosapride Business (2019-2024)
11.4.5 Nihon Generic Recent Development
11.5 NIPPON CHEMIPHAR CO., LTD.
11.5.1 NIPPON CHEMIPHAR CO., LTD. Company Detail
11.5.2 NIPPON CHEMIPHAR CO., LTD. Business Overview
11.5.3 NIPPON CHEMIPHAR CO., LTD. Mosapride Introduction
11.5.4 NIPPON CHEMIPHAR CO., LTD. Revenue in Mosapride Business (2019-2024)
11.5.5 NIPPON CHEMIPHAR CO., LTD. Recent Development
11.6 Lunan Pharmaceutical Group
11.6.1 Lunan Pharmaceutical Group Company Detail
11.6.2 Lunan Pharmaceutical Group Business Overview
11.6.3 Lunan Pharmaceutical Group Mosapride Introduction
11.6.4 Lunan Pharmaceutical Group Revenue in Mosapride Business (2019-2024)
11.6.5 Lunan Pharmaceutical Group Recent Development
11.7 HAOSON PHARMA
11.7.1 HAOSON PHARMA Company Detail
11.7.2 HAOSON PHARMA Business Overview
11.7.3 HAOSON PHARMA Mosapride Introduction
11.7.4 HAOSON PHARMA Revenue in Mosapride Business (2019-2024)
11.7.5 HAOSON PHARMA Recent Development
11.8 DAIICHI SANKYO
11.8.1 DAIICHI SANKYO Company Detail
11.8.2 DAIICHI SANKYO Business Overview
11.8.3 DAIICHI SANKYO Mosapride Introduction
11.8.4 DAIICHI SANKYO Revenue in Mosapride Business (2019-2024)
11.8.5 DAIICHI SANKYO Recent Development
11.9 SAWAI PHARMACEUTICAL CO., LTD.
11.9.1 SAWAI PHARMACEUTICAL CO., LTD. Company Detail
11.9.2 SAWAI PHARMACEUTICAL CO., LTD. Business Overview
11.9.3 SAWAI PHARMACEUTICAL CO., LTD. Mosapride Introduction
11.9.4 SAWAI PHARMACEUTICAL CO., LTD. Revenue in Mosapride Business (2019-2024)
11.9.5 SAWAI PHARMACEUTICAL CO., LTD. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Mosapride Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Tablet
Table 3. Key Players of Capsule
Table 4. Key Players of Others
Table 5. Global Mosapride Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Mosapride Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Mosapride Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Mosapride Market Share by Region (2019-2024)
Table 9. Global Mosapride Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Mosapride Market Share by Region (2025-2030)
Table 11. Mosapride Market Trends
Table 12. Mosapride Market Drivers
Table 13. Mosapride Market Challenges
Table 14. Mosapride Market Restraints
Table 15. Global Mosapride Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Mosapride Market Share by Players (2019-2024)
Table 17. Global Top Mosapride Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mosapride as of 2023)
Table 18. Ranking of Global Top Mosapride Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Mosapride Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Mosapride Product Solution and Service
Table 22. Date of Enter into Mosapride Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Mosapride Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Mosapride Revenue Market Share by Type (2019-2024)
Table 26. Global Mosapride Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Mosapride Revenue Market Share by Type (2025-2030)
Table 28. Global Mosapride Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Mosapride Revenue Market Share by Application (2019-2024)
Table 30. Global Mosapride Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Mosapride Revenue Market Share by Application (2025-2030)
Table 32. North America Mosapride Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Mosapride Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Mosapride Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Mosapride Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Mosapride Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Mosapride Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Mosapride Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Mosapride Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Mosapride Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Mosapride Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Mosapride Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Mosapride Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Mosapride Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Mosapride Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Mosapride Market Size by Country (2025-2030) & (US$ Million)
Table 47. Sumitomo Dainippon Pharma Company Detail
Table 48. Sumitomo Dainippon Pharma Business Overview
Table 49. Sumitomo Dainippon Pharma Mosapride Product
Table 50. Sumitomo Dainippon Pharma Revenue in Mosapride Business (2019-2024) & (US$ Million)
Table 51. Sumitomo Dainippon Pharma Recent Development
Table 52. Konghong Pharmaceutical Company Detail
Table 53. Konghong Pharmaceutical Business Overview
Table 54. Konghong Pharmaceutical Mosapride Product
Table 55. Konghong Pharmaceutical Revenue in Mosapride Business (2019-2024) & (US$ Million)
Table 56. Konghong Pharmaceutical Recent Development
Table 57. Dainippon Pharmaceutical Co., Ltd. Company Detail
Table 58. Dainippon Pharmaceutical Co., Ltd. Business Overview
Table 59. Dainippon Pharmaceutical Co., Ltd. Mosapride Product
Table 60. Dainippon Pharmaceutical Co., Ltd. Revenue in Mosapride Business (2019-2024) & (US$ Million)
Table 61. Dainippon Pharmaceutical Co., Ltd. Recent Development
Table 62. Nihon Generic Company Detail
Table 63. Nihon Generic Business Overview
Table 64. Nihon Generic Mosapride Product
Table 65. Nihon Generic Revenue in Mosapride Business (2019-2024) & (US$ Million)
Table 66. Nihon Generic Recent Development
Table 67. NIPPON CHEMIPHAR CO., LTD. Company Detail
Table 68. NIPPON CHEMIPHAR CO., LTD. Business Overview
Table 69. NIPPON CHEMIPHAR CO., LTD. Mosapride Product
Table 70. NIPPON CHEMIPHAR CO., LTD. Revenue in Mosapride Business (2019-2024) & (US$ Million)
Table 71. NIPPON CHEMIPHAR CO., LTD. Recent Development
Table 72. Lunan Pharmaceutical Group Company Detail
Table 73. Lunan Pharmaceutical Group Business Overview
Table 74. Lunan Pharmaceutical Group Mosapride Product
Table 75. Lunan Pharmaceutical Group Revenue in Mosapride Business (2019-2024) & (US$ Million)
Table 76. Lunan Pharmaceutical Group Recent Development
Table 77. HAOSON PHARMA Company Detail
Table 78. HAOSON PHARMA Business Overview
Table 79. HAOSON PHARMA Mosapride Product
Table 80. HAOSON PHARMA Revenue in Mosapride Business (2019-2024) & (US$ Million)
Table 81. HAOSON PHARMA Recent Development
Table 82. DAIICHI SANKYO Company Detail
Table 83. DAIICHI SANKYO Business Overview
Table 84. DAIICHI SANKYO Mosapride Product
Table 85. DAIICHI SANKYO Revenue in Mosapride Business (2019-2024) & (US$ Million)
Table 86. DAIICHI SANKYO Recent Development
Table 87. SAWAI PHARMACEUTICAL CO., LTD. Company Detail
Table 88. SAWAI PHARMACEUTICAL CO., LTD. Business Overview
Table 89. SAWAI PHARMACEUTICAL CO., LTD. Mosapride Product
Table 90. SAWAI PHARMACEUTICAL CO., LTD. Revenue in Mosapride Business (2019-2024) & (US$ Million)
Table 91. SAWAI PHARMACEUTICAL CO., LTD. Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Mosapride Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Mosapride Market Share by Type: 2023 VS 2030
Figure 3. Tablet Features
Figure 4. Capsule Features
Figure 5. Others Features
Figure 6. Global Mosapride Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Mosapride Market Share by Application: 2023 VS 2030
Figure 8. Gastritis Case Studies
Figure 9. Dyspepsia Case Studies
Figure 10. Others Case Studies
Figure 11. Mosapride Report Years Considered
Figure 12. Global Mosapride Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Mosapride Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Mosapride Market Share by Region: 2023 VS 2030
Figure 15. Global Mosapride Market Share by Players in 2023
Figure 16. Global Top Mosapride Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mosapride as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Mosapride Revenue in 2023
Figure 18. North America Mosapride Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Mosapride Market Share by Country (2019-2030)
Figure 20. United States Mosapride Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Mosapride Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Mosapride Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Mosapride Market Share by Country (2019-2030)
Figure 24. Germany Mosapride Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Mosapride Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Mosapride Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Mosapride Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Mosapride Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Mosapride Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Mosapride Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Mosapride Market Share by Region (2019-2030)
Figure 32. China Mosapride Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Mosapride Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Mosapride Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Mosapride Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Mosapride Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Mosapride Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Mosapride Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Mosapride Market Share by Country (2019-2030)
Figure 40. Mexico Mosapride Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Mosapride Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Mosapride Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Mosapride Market Share by Country (2019-2030)
Figure 44. Turkey Mosapride Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Mosapride Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Sumitomo Dainippon Pharma Revenue Growth Rate in Mosapride Business (2019-2024)
Figure 47. Konghong Pharmaceutical Revenue Growth Rate in Mosapride Business (2019-2024)
Figure 48. Dainippon Pharmaceutical Co., Ltd. Revenue Growth Rate in Mosapride Business (2019-2024)
Figure 49. Nihon Generic Revenue Growth Rate in Mosapride Business (2019-2024)
Figure 50. NIPPON CHEMIPHAR CO., LTD. Revenue Growth Rate in Mosapride Business (2019-2024)
Figure 51. Lunan Pharmaceutical Group Revenue Growth Rate in Mosapride Business (2019-2024)
Figure 52. HAOSON PHARMA Revenue Growth Rate in Mosapride Business (2019-2024)
Figure 53. DAIICHI SANKYO Revenue Growth Rate in Mosapride Business (2019-2024)
Figure 54. SAWAI PHARMACEUTICAL CO., LTD. Revenue Growth Rate in Mosapride Business (2019-2024)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
